Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia

Pediatric acute myeloid leukemia (AML) represents 20% of total childhood leukemia diagnoses and is characterized by poor prognosis with a long-term survival rate around the 50%, when patients are properly treated. The standard treatment for pediatric AML currently consists in a combination of cytara...

Descripción completa

Detalles Bibliográficos
Autores principales: Argenziano, Maura, Tortora, Chiara, Paola, Alessandra Di, Pota, Elvira, Martino, Martina Di, Pinto, Daniela Di, Leva, Caterina Di, Rossi, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274721/
https://www.ncbi.nlm.nih.gov/pubmed/34262648
http://dx.doi.org/10.18632/oncotarget.28000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274721/
https://www.ncbi.nlm.nih.gov/pubmed/34262648
http://dx.doi.org/10.18632/oncotarget.28000

Ejemplares similares